5 Largest Biotech Companies in the US

In this article, we take a look at the 5 largest biotech companies in the US. If you want to check out our detailed analysis of the biotech industry, go directly to the 27 Largest Biotech Companies in the US.

5. AbbVie Inc. (NYSE:ABBV)

2022 Revenue: $58.05 billion

Abbvie is a biomedical company that develops medicine for fighting cancers, cystic fibrosis, neurological diseases, and eye ailments. In 2020, the company acquired Allergan, a medical aesthetics company that produces Botox, a famous drug used for cosmetic purposes.

4. Merck & Co., Inc. (NYSE:MRK)

2022 Revenue: $59.3 billion

Merck & Co. is an American biotech and pharmaceutical company that develops and produces vaccines, medicines, and therapies for human and animal health. In Q1 of 2023, the company experienced a decrease of $1.4 billion in sales, compared to the first quarter of 2022. However, the sales revenue still exceeded the expectations of analysts for the given time period. 

3. Roche Holding AG

2022 Revenue: $69.17 billion

Roche Holdings is a Swiss pharmaceutical and diagnostics company that focuses on combatting cardiometabolic diseases, inflammatory bowel diseases, and infectious diseases, among others. The company also owns Genentech, a leading biotech firm, which discovered the first targeted antibody to fight cancer.

2. Johnson & Johnson (NYSE:JNJ)

2022 Revenue: $94.9 billion

Johnson & Johnson is a biotechnology and pharmaceutical firm, which is also famous for its production of consumer packaged goods. The company faced a decrease of 4.4% in sales during the fourth quarter of 2022, which, according to Investopedia, was largely due to exchange rate issues and a decline in post-Covid vaccine sales.

1. Pfizer Inc. (NYSE:PFE)

2022 Revenue: $100.3 billion

Pfizer is one of the leading firms in the biotech and pharmaceutical sectors across the world. Its famous products include Advil, Viagra, and Comirnaty, the vaccine developed for Covid-19. The vaccine singlehandedly generated a revenue of $37.8 billion for the company in 2022.

Disclosure: None. You can also take a look at 12 Most Advanced Countries in Biotechnology and 5 Cheap Biotech Stocks To Buy.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newletter to get the latest investment ideas from hedge funds’ investors letters by entering your email address below.

Follow Insider Monkey on Twitter